• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉毒毒素治疗强直性前斜颈:注射什么。

Botulinum toxin treatment of dystonic anterocollis: What to inject.

机构信息

Neurology, London BTX Centre, London, United Kingdom.

ENT Department, St George's Hospital NHS Foundation Trust, London, United Kingdom.

出版信息

Parkinsonism Relat Disord. 2021 Jul;88:34-39. doi: 10.1016/j.parkreldis.2021.05.024. Epub 2021 May 29.

DOI:10.1016/j.parkreldis.2021.05.024
PMID:34102419
Abstract

BACKGROUND

Anterocollis (AC) is a rare form of cervical dystonia, which responds poorly to botulinum toxin treatment.

OBJECTIVES

To recognise the different clinical phenotypes of AC and to detail the selection of muscles from the results of treating a cohort of 15 AC patients with Botulinum Toxin.

METHODS

The study was performed using prospectively collected data. We included 15 patients with cervical dystonia and AC posture, treated between 2016 and 2019 in our joint Neuro-ENT clinic. We excluded patients with posterior cervical muscle weakness and patients with Parkinsonism. We characterised the primary dystonic posture of every AC patient as posterior sagittal shift, head flexion or neck flexion, or a combination of the three.

RESULTS

All AC patients had a more widespread dystonic picture with a majority having Meige syndrome, but AC was the most problematic feature. Treatment with botulinum toxin required the injection not only of the deep cervical flexor (DCF), but also the sterno-cleido-mastoid (SCM) and moreover the supra-hyoid (SH) muscles. The choice between the longus capiti and the longus colli depended on the AC posture. Half of the patients had a dramatic improvement with 90% satisfaction or above.

CONCLUSION

AC posture is a complex but treatable type of CD. A joint Neuro-ENT clinic is an ideal setting in which to target all the dystonic muscles. This allows the injection of the longus capiti (under nasal endoscopic approach) as well as the supra-hyoid and SCM muscles in the same session.

摘要

背景

前屈颈(AC)是一种罕见的颈部肌张力障碍形式,对肉毒毒素治疗反应不佳。

目的

认识 AC 的不同临床表型,并详细说明从治疗 15 例 AC 患者的肉毒毒素治疗结果中选择肌肉。

方法

本研究采用前瞻性收集的数据进行。我们纳入了 2016 年至 2019 年间在我们的神经耳科联合诊所治疗的 15 例患有颈部肌张力障碍和 AC 姿势的患者。我们排除了有颈部后肌无力和帕金森病的患者。我们将每个 AC 患者的原发性张力障碍姿势特征化为后矢状移位、头部前屈或颈部前屈,或三者的组合。

结果

所有 AC 患者都有更广泛的张力障碍表现,大多数患者有 Meige 综合征,但 AC 是最成问题的特征。肉毒毒素治疗需要不仅注射深部颈屈肌(DCF),还需要注射胸锁乳突肌(SCM),而且还需要注射舌骨上肌(SH)。长头肌和长颈肌的选择取决于 AC 的姿势。一半的患者有明显的改善,90%以上的患者满意度在 90%以上。

结论

AC 姿势是一种复杂但可治疗的 CD 类型。神经耳科联合诊所是靶向所有张力障碍肌肉的理想场所。这允许在同一治疗中注射长头肌(经鼻内窥镜入路)以及舌骨上肌和 SCM 肌肉。

相似文献

1
Botulinum toxin treatment of dystonic anterocollis: What to inject.肉毒毒素治疗强直性前斜颈:注射什么。
Parkinsonism Relat Disord. 2021 Jul;88:34-39. doi: 10.1016/j.parkreldis.2021.05.024. Epub 2021 May 29.
2
Anterior and posterior sagittal shift in cervical dystonia: a clinical and electromyographic study, including a new EMG approach of the longus colli muscle.颈源性斜颈的前后矢状移位:一项临床和肌电图研究,包括长颈肌新的肌电图方法。
Mov Disord. 2011 Nov;26(13):2409-14. doi: 10.1002/mds.23905. Epub 2011 Sep 12.
3
Fluoroscopic, EMG-guided injection of botulinum toxin into the longus colli for the treatment of anterocollis.透视、肌电图引导下长颈肌注射肉毒毒素治疗前屈颈肌痉挛。
Parkinsonism Relat Disord. 2009 Sep;15(8):610-3. doi: 10.1016/j.parkreldis.2009.01.006. Epub 2009 Feb 27.
4
Ultrasound and Electromyography Guidance for Injection of the Longus Colli With Botulinum Toxin for the Treatment of Cervical Dystonia.超声和肌电图引导下肉毒杆菌毒素注射颈长肌治疗颈部肌张力障碍
Ultrasound Q. 2016 Sep;32(3):302-6. doi: 10.1097/RUQ.0000000000000226.
5
Management of Anterocapitis and Anterocollis: A Novel Ultrasound Guided Approach Combined with Electromyography for Botulinum Toxin Injection of Longus Colli and Longus Capitis.前颈椎和前斜颈的管理:一种新的超声引导方法,结合肌电图,用于颈长肌和头长肌肉毒毒素注射。
Toxins (Basel). 2020 Sep 30;12(10):626. doi: 10.3390/toxins12100626.
6
Endoscopic Injection of the Longus Capiti Muscle in the Treatment of Dystonic Head Flexion.内镜下头长肌注射治疗肌张力障碍性头部前屈
Mov Disord Clin Pract. 2020 Mar 11;7(3):293-297. doi: 10.1002/mdc3.12916. eCollection 2020 Apr.
7
A methodological approach for botulinum neurotoxin injections to the longus colli muscle in dystonic anterocollis: A case series of 4 patients and a literature review.一种用于痉挛性前斜颈中 longus colli 肌肉的肉毒毒素注射的方法学:4 例病例系列和文献复习。
J Clin Neurosci. 2020 Oct;80:188-194. doi: 10.1016/j.jocn.2020.08.025. Epub 2020 Aug 26.
8
Sonographic guidance provides a low-risk approach to the longus colli muscle.超声引导为颈长肌提供了一种低风险的方法。
Mov Disord. 2012 Jun;27(7):928-9; author reply 929. doi: 10.1002/mds.25024. Epub 2012 May 30.
9
Bilateral Lower Sternocleidomastoid Botulinum Toxin Injections to Address Refractory Anterocollis.双侧胸锁乳突肌注射肉毒杆菌毒素治疗难治性前斜颈。
Neurologist. 2016 Mar;21(2):30-1. doi: 10.1097/NRL.0000000000000072.
10
Treatment of complex cervical dystonia with botulinum toxin: involvement of deep-cervical muscles may contribute to suboptimal responses.肉毒毒素治疗复杂型颈肌张力障碍:深层颈肌的参与可能导致反应不佳。
Parkinsonism Relat Disord. 2011 Nov;17 Suppl 1:S20-4. doi: 10.1016/j.parkreldis.2011.06.015.

引用本文的文献

1
Comparison of Guided and Unguided Botulinum Injections for Cervical Dystonia: EMG, Ultrasound, and Anatomic Landmarks.肉毒杆菌注射治疗颈部肌张力障碍的引导与非引导方法比较:肌电图、超声及解剖标志
CNS Neurol Disord Drug Targets. 2025;24(7):546-553. doi: 10.2174/0118715273304250241226051604.
2
Update on Non-Interchangeability of Botulinum Neurotoxin Products.肉毒毒素产品不可互换性的最新进展。
Toxins (Basel). 2024 Jun 10;16(6):266. doi: 10.3390/toxins16060266.
3
Clinical neurophysiology in the treatment of movement disorders: IFCN handbook chapter.
临床神经生理学在运动障碍治疗中的应用:国际临床神经生理联合会手册章节
Clin Neurophysiol. 2024 Aug;164:57-99. doi: 10.1016/j.clinph.2024.05.007. Epub 2024 May 23.
4
Botulinum Toxin Injection into the Digastric Muscle: Current Clinical Use and a Report of Five Cases.肉毒杆菌毒素注射入二腹肌:当前临床应用及五例报告
Biomedicines. 2023 Oct 12;11(10):2767. doi: 10.3390/biomedicines11102767.